Nanogen Inc (NASDAQ NGEN)., which develops medical test products, said it asked the Food and Drug Administration to approve its cystic fibrosis test kit and the Nanochip 400 microarray system.

The kit is intended to be used for carrier testing in adults, newborn screening and confirmatory tests in newborns and children. The nanochip system is an automated platform used for genetic sequencing.